MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: U.S. Federal
*Funding: HHS
*HHS: Contracts, Contractors & Awards
*BARDA: Contracts (IDIQ, GWACS, Etc.), Contractors & Awardees
*Contractors & Awardees: BARDA
OraSure Technologies, Inc. (NASDAQ:OSUR)
Organization & Developments: Orasure
Parents
OraSure Technologies, Inc. (NASDAQ:OSUR)
Children
*Leader in point-of-need and home diagnostic tests and sample management solutions
*One of the latest products from OraSure Technologies, a rapid test for hepatitis C, has been recognized by the magazine Popular Science as one of the top 100 technological innovations of the year.
*ORAQUICK EBOLA RAPID ANTIGEN TEST
*Produces, manufactures and sells oral fluid specimen collection devices for testing and technology purposes, sold nationally and internationally, to hospitals, clinics, doctors' offices, labs and more.
2010: OraSure honored for new product (2010)
2014: OraSure Technologies Inc Inks Co Promotion Pact With AbbVie Worth 75 Million Plus Milestones
2017: BARDA_Broad Agency Announcement (BAA) for Advanced Research and Development to Expedite the Identification, Development, and Manufacturing of Medical Countermeasures against Infectious Diseases
2020: OraSure nabs BARDA contract for COVID-19 antibody test
2021: OraSure gets $109M Department of Defense contract
2021: OraSure Getting Up To $13.6M From Feds for COVID-19 Rapid Test 510(k) Clearance
2022: OraSure wins $8.6M government contract for next-gen Ebola test_seekingalpha.com
2024: BARDA_OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
Jumps
*Key People: Orasure
Finance & Acquisitions: Orasure